Sorafenib is US FDA approved for the treatment of advanced renal cell carcinoma and unresectable hepatocellular carcinoma. The recommended single-agent dose is 400 mg orally twice a day ...

Median progression-free survival was similar between immunotherapy and lenvatinib or sorafenib (hazard ratio [HR] 0·87 ... treatment strategies in most patients with unresectable hepatocellular ...

Tremelimumab has been approved by the FDA in the US for use in tandem with AZ's PD-L1 inhibitor Imfinzi (durvalumab) to treat adults with unresectable hepatocellular carcinoma (HCC), the most ...

Prevalence and risk factors Hepatocellular carcinoma (HCC), the most common ... Targeted therapy: Drugs such as sorafenib and lenvatinib block specific pathways that promote cancer growth ...

as a first-line therapy for unresectable hepatocellular carcinoma (HCC) – the most common form of liver cancer – by 21st April next year. Approval would make an Opdivo regimen an option for ...

Solute carrier family 25 member 19 (SLC25A19) is a transporter protein of thiamine pyrophosphate across cellular membranes, which is needed as a cofactor for multiple metabolic enzymes and is ...

The risk of dying from the most common form of primary liver cancer is about 30% higher for patients with low household ...

Background: Hepatoblastoma (HBL) and hepatocellular carcinoma (HCC) are respectively the first and the second most common pediatric malignant liver tumors. The purpose of this study was to ...

Cancer Sun, Moon and rising natives will have only one focus, that's their career. Two benefic planets, Venus and Mercury will be in your tenth house, which is an exceptional and good transit to ...